Also, given the association that high plasma level of GDF-15 decreases time to recurrence, further emphasizes that GDF-15 is increased due to the patient’s cancer status as reduced time to recurrence is not likely to be influenced by cardiovascular disease. This evidence concerns the gene GDF15 and cancer.